Clin2
NCT06626984Possibly a fitNot yet recruiting

Study of new and existing drugs for sepsis in healthy volunteers

SepsisFluid OverloadEndothelial DysfunctionMicrocirculation

Treatments studied

Part of Infections clinical trials.

This trial tests new and existing drugs in healthy volunteers to see how they affect the body's response to a substance that mimics sepsis. It helps researchers understand how these drugs might work in people with sepsis.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1/Phase 2
Enrollment
65 people
Ages
18 years to 40 years
Study type
Interventional

Who can take part

  • You are a healthy adult between 18 and 40 years old
  • You are not currently in another clinical trial
  • You are not pregnant or breastfeeding
  • You do not smoke
  • You drink fewer than 21 units of alcohol per week
  • You are not taking any regular prescription or over-the-counter medications

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06910891Recruiting
Studying microcirculation to treat sepsis early

This trial tests a special way to monitor tiny blood vessels (microcirculation) in patients with sepsis. The goal is to see if early treatment based on these readings can help improve recovery.

Brivé
NCT06854640Recruiting· Phase 1
Safety and dosing study for a new sepsis-related blood clotting treatment

This study tests a new drug (BAY 3389934) for people with sepsis who also have a blood clotting problem. It aims to find the right dose and make sure the drug is safe.

Edegem
NCT07160426Not yet recruiting· Phase 2
Protecting blood vessel lining in severe infections

This trial tests if a special fluid given through a vein can protect and repair the lining of your blood vessels during sepsis. Sepsis is a dangerous reaction to an infection that can damage organs. This study aims to see if this treatment helps patients in the intensive care unit (ICU) recover better.

NCT07353970Not yet recruiting
Study on recovery molecules in severe infections

This trial looks at natural molecules that help the body resolve severe infections. Researchers want to understand how these molecules affect recovery and identify patient types that respond best. It may help improve treatment for people in the ICU with serious infections.

NCT07733206Not yet recruiting
A new test to guide fluid therapy for sepsis patients

This study is testing a new way of measuring how much fluid leaks from your blood vessels during severe infection (septic shock). The goal is to help doctors decide how much fluid to give, which may improve recovery and prevent complications.

Fort-de-France, Martinique
NCT07667153Not yet recruiting
Sepsis and bone marrow function study

This study is looking at how sepsis affects bone marrow to understand why some people get very sick. If you are in the ICU with a serious infection or another critical illness, you may be eligible to join.

Hear when a new Sepsis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.